Health Catalyst, Inc.

NasdaqGS:HCAT 주식 보고서

시가총액: US$357.2m

이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

Health Catalyst 관리

관리 기준 확인 3/4

Health Catalyst's CEO는 Dan Burton, Oct2012 에 임명되었습니다 의 임기는 11.67 년입니다. 총 연간 보상은 $ 4.44M, 3.4% 로 구성됩니다. 3.4% 급여 및 96.6% 보너스(회사 주식 및 옵션 포함). 는 $ 5.41M 가치에 해당하는 회사 주식의 1.45% 직접 소유합니다. 5.41M. 경영진과 이사회의 평균 재임 기간은 각각 2.3 년과 7.1 년입니다.

주요 정보

Dan Burton

최고 경영자

US$4.4m

총 보상

CEO 급여 비율3.4%
CEO 임기11.7yrs
CEO 소유권1.4%
경영진 평균 재임 기간2.3yrs
이사회 평균 재임 기간7.1yrs

최근 관리 업데이트

Recent updates

Health Catalyst: Stellar Earnings Growth Projected

Jun 26

Health Catalyst, Inc. (NASDAQ:HCAT) First-Quarter Results: Here's What Analysts Are Forecasting For This Year

May 12
Health Catalyst, Inc. (NASDAQ:HCAT) First-Quarter Results: Here's What Analysts Are Forecasting For This Year

Benign Growth For Health Catalyst, Inc. (NASDAQ:HCAT) Underpins Its Share Price

Apr 04
Benign Growth For Health Catalyst, Inc. (NASDAQ:HCAT) Underpins Its Share Price

Health Catalyst: Achieving FY28 Long-Term Guidance Is Possible

Mar 09

Health Catalyst Looks To Slim Down As It Faces Industry Headwinds (Downgrade)

Feb 16

Is Health Catalyst (NASDAQ:HCAT) A Risky Investment?

Jan 27
Is Health Catalyst (NASDAQ:HCAT) A Risky Investment?

What Health Catalyst, Inc.'s (NASDAQ:HCAT) 25% Share Price Gain Is Not Telling You

Dec 24
What Health Catalyst, Inc.'s (NASDAQ:HCAT) 25% Share Price Gain Is Not Telling You

Is Health Catalyst, Inc. (NASDAQ:HCAT) Trading At A 47% Discount?

Dec 15
Is Health Catalyst, Inc. (NASDAQ:HCAT) Trading At A 47% Discount?

Is Health Catalyst (NASDAQ:HCAT) Weighed On By Its Debt Load?

Oct 24
Is Health Catalyst (NASDAQ:HCAT) Weighed On By Its Debt Load?

Subdued Growth No Barrier To Health Catalyst, Inc.'s (NASDAQ:HCAT) Price

Jul 31
Subdued Growth No Barrier To Health Catalyst, Inc.'s (NASDAQ:HCAT) Price

Is Health Catalyst (NASDAQ:HCAT) Using Too Much Debt?

Jun 27
Is Health Catalyst (NASDAQ:HCAT) Using Too Much Debt?

Is Health Catalyst (NASDAQ:HCAT) Using Too Much Debt?

Feb 22
Is Health Catalyst (NASDAQ:HCAT) Using Too Much Debt?

Health Catalyst, Inc. (NASDAQ:HCAT) Shares Could Be 22% Above Their Intrinsic Value Estimate

Dec 06
Health Catalyst, Inc. (NASDAQ:HCAT) Shares Could Be 22% Above Their Intrinsic Value Estimate

Is Health Catalyst (NASDAQ:HCAT) Using Debt In A Risky Way?

Nov 03
Is Health Catalyst (NASDAQ:HCAT) Using Debt In A Risky Way?

Health Catalyst: Looking For A Turnaround For This 'Bio Boom' Candidate

Oct 14

Health Catalyst names Kevin Freeman as Chief Growth Officer, Tarah Bryan as Chief Marketing Officer, Dave Ross as Chief Technology Officer

Sep 07

Health Catalyst Non-GAAP EPS of -$0.03 beats by $0.07, revenue of $70.63M beats by $0.75M

Aug 04

Is Health Catalyst (NASDAQ:HCAT) A Risky Investment?

Jul 26
Is Health Catalyst (NASDAQ:HCAT) A Risky Investment?

CEO 보상 분석

Dan Burton 의 보수는 Health Catalyst 의 수익과 비교하여 어떻게 변경되었나요?
날짜총 보상급여회사 수익
Mar 31 2024n/an/a

-US$106m

Dec 31 2023n/an/a

-US$118m

Sep 30 2023n/an/a

-US$124m

Jun 30 2023n/an/a

-US$147m

Mar 31 2023n/an/a

-US$148m

Dec 31 2022US$4mUS$150k

-US$137m

Sep 30 2022n/an/a

-US$151m

Jun 30 2022n/an/a

-US$145m

Mar 31 2022n/an/a

-US$147m

Dec 31 2021US$6mUS$300k

-US$153m

Sep 30 2021n/an/a

-US$147m

Jun 30 2021n/an/a

-US$135m

Mar 31 2021n/an/a

-US$126m

Dec 31 2020US$5mUS$315k

-US$115m

Sep 30 2020n/an/a

-US$86m

Jun 30 2020n/an/a

-US$99m

Mar 31 2020n/an/a

-US$181m

Dec 31 2019US$4mUS$350k

-US$241m

Sep 30 2019n/an/a

-US$304m

Jun 30 2019n/an/a

-US$282m

Mar 31 2019n/an/a

-US$190m

Dec 31 2018US$5mUS$315k

-US$114m

보상 대 시장: Dan 의 총 보상 ($USD 4.44M )은 US 시장( $USD 2.46M ).

보상과 수익: Dan 의 보상은 지난 한 해 동안 회사 성과와 일치했습니다.

CEO

Dan Burton (49 yo)

11.7yrs

테뉴어

Mr. Daniel D. Burton, also known as Dan, has been the Chief Executive Officer of Health Catalyst, Inc. since October 2012 and has been its Director since September 2011. Mr. Burton has strategy and leaders...

리더십 팀

이름위치테뉴어보상소유권
Daniel Burton
CEO & Director11.7yrs데이터 없음1.45%
$ 5.2m
Jason Alger
Chief Financial Officerless than a yearUS$823.62k0.20%
$ 714.9k
Benjamin Landry
General Counsel & Secretary of the Board1.1yrsUS$946.31k0%
$ 0
Linda Llewelyn
Chief People Officer6.3yrsUS$1.06m0.032%
$ 112.9k
Daniel LeSueur
Chief Operating Officerless than a year데이터 없음0.10%
$ 357.7k
Dave Ross
Chief Technology Officer1.8yrs데이터 없음데이터 없음
Adam Brown
Senior Vice President of Investor Relations and Financial Planning & Analysis3.4yrs데이터 없음데이터 없음
Tarah Bryan
Chief Marketing & Communications Officer2.3yrs데이터 없음데이터 없음
Kyle Salyers
Chief Strategy Officer & Senior VP of Corporate Developmentno data데이터 없음데이터 없음
Jeffrey Selander
Senior Vice President of International5.1yrs데이터 없음데이터 없음
Holly Rimmasch
Senior VP & Chief Clinical Officerno data데이터 없음데이터 없음
Leslie Falk
Chief Client Success Officerno data데이터 없음데이터 없음

2.3yrs

평균 재임 기간

46yo

평균 연령

경험이 풍부한 관리: HCAT 의 관리팀은 경험 ( 2.3 년 평균 재직 기간)으로 간주됩니다.

이사회 구성원

이름위치테뉴어보상소유권
Daniel Burton
CEO & Director12.8yrs데이터 없음1.45%
$ 5.2m
John Kane
Independent Chairman8.3yrsUS$316.16k0.19%
$ 666.6k
Julie Larson-Green
Independent Director4.4yrsUS$233.49k0.075%
$ 268.8k
S. Smith
Independent Director4.4yrsUS$237.25k0.076%
$ 270.2k
Anita Pramoda
Independent Director8.2yrsUS$244.77k0.056%
$ 201.3k
Duncan Gallagher
Independent Director7.1yrsUS$244.77k0.091%
$ 325.0k
Matthew Kolb
Independent Directorless than a year데이터 없음데이터 없음

7.1yrs

평균 재임 기간

60yo

평균 연령

경험이 풍부한 이사회: HCAT 의 이사회는 경험(평균 재직 기간 7.1 년)으로 간주됩니다.